We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Direct Relationship Found Between Two Antibodies and AD Severity

By LabMedica International staff writers
Posted on 19 Mar 2009
A direct relationship has been discovered between two specific antibodies and the severity of Alzheimer's disease symptoms, raising hopes that a diagnostic blood test for the devastating disorder is within reach.

The body creates antibodies in response to two proteins that are associated with Alzheimer's disease. More...
One protein, known as amyloid-beta, forms the plaques that are evident in the brains of people with Alzheimer's upon autopsy. The other protein, known as RAGE, is involved in the normal aging process but is expressed at higher levels in the brains of people with Alzheimer's.

Scientists from the University of Georgia (Athens, GA, USA), the Charlie Norwood VA Medical Center in Augusta (Augusta, GA, USA), and the Medical College of Georgia (Augusta, GA, USA) compared antibody levels in blood samples from 118 older adults with the participant's level of dementia. The team found that the concentration of two specific proteins that are involved in the immune response increases as the severity of dementia increases.

"We found a strong and consistent relationship between two particular antibodies and the level of impairment," said Professor L. Stephen Miller, director of clinical psychology training in the UGA Franklin College of Arts and Sciences. "The finding brings us closer to our ultimate goal of developing a blood test that can diagnose Alzheimer's disease or potentially identify if someone is at higher risk for the disease."

Related Links:

University of Georgia
Charlie Norwood VA Medical Center in Augusta
Medical College of Georgia




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
New
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.